Quoin Pharmaceuticals Ltd. (QNRX)
6.97
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 14:19
Quoin Pharmaceuticals Market Cap : 14.00M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 14.00M |
| September 08, 2026 | 14.36M |
| September 04, 2026 | 14.58M |
| September 03, 2026 | 15.81M |
| September 02, 2026 | 13.54M |
| September 01, 2026 | 13.07M |
| August 31, 2026 | 12.49M |
| August 28, 2026 | 12.29M |
| August 27, 2026 | 10.35M |
| August 26, 2026 | 10.40M |
| August 25, 2026 | 10.18M |
| August 24, 2026 | 10.89M |
| August 21, 2026 | 11.19M |
| August 20, 2026 | 10.02M |
| August 19, 2026 | 9.480M |
| August 18, 2026 | 9.982M |
| August 17, 2026 | 10.42M |
| August 14, 2026 | 10.22M |
| August 13, 2026 | 12.15M |
| August 12, 2026 | 11.83M |
| August 11, 2026 | 10.49M |
| August 10, 2026 | 10.51M |
| August 07, 2026 | 9.394M |
| August 06, 2026 | 8.963M |
| August 05, 2026 | 8.570M |
| Date | Value |
|---|---|
| August 04, 2026 | 8.531M |
| August 03, 2026 | 8.727M |
| July 31, 2026 | 8.727M |
| July 30, 2026 | 8.629M |
| July 29, 2026 | 8.384M |
| July 28, 2026 | 8.237M |
| July 27, 2026 | 8.414M |
| July 24, 2026 | 8.394M |
| July 23, 2026 | 8.570M |
| July 22, 2026 | 8.580M |
| July 21, 2026 | 8.355M |
| July 20, 2026 | 8.257M |
| July 17, 2026 | 8.316M |
| July 16, 2026 | 8.159M |
| July 15, 2026 | 8.257M |
| July 14, 2026 | 8.531M |
| July 13, 2026 | 8.296M |
| July 10, 2026 | 8.727M |
| July 09, 2026 | 9.159M |
| July 08, 2026 | 9.257M |
| July 07, 2026 | 9.414M |
| July 06, 2026 | 9.022M |
| July 02, 2026 | 8.982M |
| July 01, 2026 | 9.237M |
| June 30, 2026 | 9.492M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.730B |
| Alnylam Pharmaceuticals, Inc. | 33.16B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.087B |
| Vericel Corp. | 1.930B |
Market Cap Related Metrics
| Price to Book Value | 3.560 |
| Price | 6.97 |
| Earnings Yield | -214.1% |